Final version published [Regulatives / Guidelines]

posted by Panks.79 – 2010-03-08 08:22 (5583 d 08:25 ago) – Posting: # 4875
Views: 23,645

Hi,

This is my first post on this forum, so kindly forgive me for any mistakes.

These guidelines are for IR products. Can this be applicable to MR product also. Can we assume that the CminSS is not required for MR product also.

Also would like to know if by anyways we can justify a steady state study that has failed at steady state for Cmin.

Thanks.

Dr. Pankaj Patil

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
33 visitors (0 registered, 33 guests [including 9 identified bots]).
Forum time: 17:47 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5